NAS:VERU (USA) Also Trade In: Germany
Warning! GuruFocus has detected 3 Severe warning signs with VERU. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Veru Inc () from 1990 to Apr 20 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Veru stock (VERU) PE ratio as of Apr 20 2021 is 0. More Details
Veru PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Veru PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
48 NW 25th Street, Suite 102, Miami, FL, USA, 33137
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.